Skip to main content

Advertisement

SpringerLink
Log in

Bortezomib therapy in myelofibrosis: a phase II clinical trial

  • Letter to the Editor
  • Published:
Leukemia Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Tefferi A, Vardiman JW . Classification and diagnosis of myeloproliferative neoplasms: the 2008 World Health Organization criteria and point-of-care diagnostic algorithms. Leukemia 2008; 22: 14–22.

    Article  CAS  PubMed  Google Scholar 

  2. Cervantes F, Mesa R, Barosi G . New and old treatment modalities in primary myelofibrosis. Cancer J 2007; 13: 377–383.

    Article  CAS  PubMed  Google Scholar 

  3. Levine RL, Pardanani A, Tefferi A, Gilliland DG . Role of JAK2 in the pathogenesis and therapy of myeloproliferative disorders. Nat Rev Cancer 2007; 7: 673–683.

    Article  CAS  PubMed  Google Scholar 

  4. Pardanani A . JAK2 inhibitor therapy in myeloproliferative disorders: rationale, preclinical studies and ongoing clinical trials. Leukemia 2008; 22: 23–30.

    Article  CAS  PubMed  Google Scholar 

  5. Tefferi A, Lasho TL, Mesa RA, Pardanani A, Ketterling RP, Hanson CA . Lenalidomide therapy in del(5)(q31)-associated myelofibrosis: cytogenetic and JAK2V617F molecular remissions. Leukemia 2007; 21: 1827–1828.

    Article  CAS  PubMed  Google Scholar 

  6. Wagner-Ballon O, Pisani DF, Gastinne T, Tulliez M, Chaligne R, Lacout C et al. Proteasome inhibitor bortezomib impairs both myelofibrosis and osteosclerosis induced by high thrombopoietin levels in mice. Blood 2007; 110: 345–353.

    Article  CAS  PubMed  Google Scholar 

  7. Shetty V, Verspoor F, Nguyen H, Gallegos A, Mundle S, Chaudry N . Effect of proteosome inhibition by bortezomib on tumor necrosis factor-alpha (TNF-alpha) and aopotosis in patients with Myelodysplastic Syndromes. Blood 2003; 106 (Suppl 1): a1534.

    Google Scholar 

  8. Barosi G, Gattoni E, Barbui T, Vannucchi AM, Rambaldi A, Silverman L et al. A phase I study of the proteasome inhibitor bortezomib in patients with myelofibrosis. Blood 2007; 110: a3540.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA

    R A Mesa, A Pardanani, K Hussein, T Lasho, W Wu & A Tefferi

  2. Department of Leukemia, MD Anderson Cancer Center, University of Texas, Houston, TX, USA

    S Verstovsek

  3. Division of Leukemia Mayo Clinic Jacksonville, Jacksonville, FL, USA

    C Rivera

Authors
  1. R A Mesa
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S Verstovsek
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C Rivera
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A Pardanani
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. K Hussein
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. T Lasho
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. W Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. A Tefferi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to R A Mesa.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mesa, R., Verstovsek, S., Rivera, C. et al. Bortezomib therapy in myelofibrosis: a phase II clinical trial. Leukemia 22, 1636–1638 (2008). https://doi.org/10.1038/leu.2008.32

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/leu.2008.32

  • Springer Nature Limited

This article is cited by

Search

Navigation